Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial
JAMA Netw Open 2023 Jun 01;6(6)e2316094, NY Lee, J Harris, J Kim, A Garden, J Mechalakos, DG Pfister, ATC Chan, K Hu, AD Colevas, S Frank, G Shenouda, V Bar-Ad, JN Waldron, PM Harari, A Raben, P Torres-Saavedra, QT LeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.